Efficacy and Safety of a Self-Improved Continuous Bladder Irrigation Sensor Device in Patients after Transurethral Resection of the Prostate: A Prospective Study
Urology Journal,
Vol. 21 (2024),
8 May 2024
,
Page 7859
https://doi.org/10.22037/uj.v21i.7859
Abstract
Purpose To explore the efficacy and safety of a self-improved continuous bladder irrigation (CBI) sensor device after transurethral resection of the prostate (TURP).
Materials and Methods A total of 160 patients with benign prostatic hyperplasia who received TURP from June 2021 to May 2022 were selected. According to the envelope randomization method, patients were divided into a control group (80 cases) and study group (80 cases). In the control group, the speed of bladder flushing fluid was adjusted according to the clinical experience of nurses. On the basis of the control group, the self-improved CBI sensor device was used in the study group to observe the postoperative comfort and complication rate in the two groups. Results The comfort of patients in the study group was significantly higher than that of patients in the control group (97.50% vs. 88.75%, P = .023), and the number of postoperative complications in the control group was significantly higher than that in the study group (8.75% vs. 1.25%, P = .021). Meanwhile, the average amount of irrigation fluid in the study group was obviously lower than that in the control group (26.4 L vs. 27.8 L, P = .011). In addition, patients in the study group had a significantly shorter hospital stay than the controls (3.3 days vs. 3.6 days, P = .005).
Conclusion Implementation of the new self-improved CBI sensor device for patients after TURP can improve their awareness regarding disease-related knowledge, alleviate their fear and anxiety, improve their compliance and comfort with treatment and nursing, and reduce the incidence of complications.
- Improvement; Continuous bladder irrigation; TURP; Nursing; Complication; Comfort
How to Cite
References
Fenter TC, Naslund MJ, Shah MB, et al. The cost of treating the 10 most prevalent diseases in men 50 years of age or older. Am J Managed Care 2006;12(4 suppl):90-8.
Jonler M, Riehmann M, Brinkmann R, et al. Benign prostatic hyperplasia. J R Soc Promot Health 2004;124:222-7.
Tammela T. Benign prostatic hyperplasia. Practical treatment guidelines. Drugs Aging 1997;10:349-66.
Okorie CO. Is continuous bladder irrigation after prostate surgery still needed? World J Clin Urol 2015;4:108-14.
Bagla S, Smirniotopoulos J, Orlando J, et al. Cost analysis of prostate artery embolization (PAE) and transurethral resection of the prostate (TURP) in the treatment of benign prostatic hyperplasia [J]. Cardiovasc Intervent Radiol, 2017, 40 (11): 1694-1697.
Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy—part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology, 2001,57(4):599-603.
Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the Prostate: A prospective multicenter evaluation of 10,654 Patients[J].J Urol, 2008, 180(1):246-249.
Bushman W. Etiology, epidemiology, and natural history of benign Prostatic hyperplasia [J]. Urol Clin North Am, 2009, 36 (4):403-415.
Ma ZZ, Han YX, Wang WZ, et al. The use of a homemade rate adjustment card in patients with continuous bladder irrigation after transurethral resection of the prostate. Transl Androl Urol 2020;9(5):2227- 2234. doi:10.21037/tau-20-1288.
Meagher A, Thompson J, Vanderpuije J. Developing and testing a urine colour reference scale: a practice development project. International Journal of Urological Nursing, 2014,8(3):122-129.
Stroup SP, Palazzi-Churas K, Kopp RP, et al. Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA, 1998 to 2008. BJU Int 2012;109:84-7.
Baszczuk A, Kopczyfiski Z, Thielemann A. Endothelial dys-function in Patients with Primary hypertension and hyperhomocys·teinemia [J].Postepy Hig Med Dosw, 2014, 68(1):91.
Guo RQ, Yu W, Meng YS, et a1. Benign prostatic obstruction-related complications with clinical outcomes in patients after transurethral resection of the prostate [J]. Kaohsiung J Med Sci, 2017, 33(3): 144-151.
Hohenfellner M, Santucci RA. Emergencies in urology [M]. Heidelberg: Springer Berlin, 2010:11-25.
Roehrborn CG, Teplitsky S, Das AK. Aquablation of the prostate: a review and update. Can J Urol 2019;26:20-4.
Ding AM, Cao HL, Wang LH, et a1. A novel automatic regulatory device for continuous bladder irrigation based on wireless sensor in patients after transurethral resection of the prostate: a prospective investigation [J]. Medicine(Baltimore), 2016, 95(52): 1-4.
Ng C. Assessment and intervention knowledge of nurses in managing catheter patency in continuous bladder irrigation following TURP. Urol Nurs 2001;21:97-111.
Ma ZZ, Niu ME. Research Progress on continuous bladder irrigation after transurethral prostatectomy (TURP). J Nurs Sci 2020;35:98-100.
Nojiri Y, Okamura K, Kinukawa T, et al. Continuous bladder irrigation following transurethral resection of the prostate (TURP). Nihon Hinyokika Gakkai Zasshi 2007;98:770-5.
Carnevale FC, Iscaife A, Yoshinaga EM, et al. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis. Cardiovasc Intervent Radiol 2016;39:44-52.
The safety of TURP in patietns taking aspirin in the introduction or discussion sections of the article to have a better literature review: Wu J, Li H, Tao R, Tang Q. The Safety and Efficacy of Bipolar Plasma-Kinetic Transurethral Resection of The Prostate in Patients Taking Low-Dose Aspirin. Urol J. 2023 Jun 21. doi: 10.22037/uj.v20i.7508. Epub ahead of print. PMID: 37341011.
- Abstract Viewed: 45 times
- Just Accepted-7859 Downloaded: 35 times